Biography
Dr. Arturo Loaiza-Bonilla, MD, MSEd, FACP is a physician–scientist and oncology executive operating at the intersection of clinical medicine, artificial intelligence, and large-scale clinical research infrastructure.
Clinical interests / subspecialty
Biomarker-driven cancers; immunotherapy; complex trial-based care; clinical trial access/matching infrastructure; neurosymbolic & multi-agent AI platforms
Education & training
Medical School: University of Miami Miller School of Medicine
Residency: St. Luke's-Roosevelt Hospital Center, Columbia University, Internal Medicine
Fellowship: Post-Doctorate Fellow, Hematology and Oncology (University of Miami Miller School of Medicine)
Other training: Master of Medical Education (MSEd), Medical Education (University of Pennsylvania)
Board certifications / licenses
- ABIM - Medical Oncology
- ABIM - Internal Medicine
Professional memberships
ASCO, AACR, ACP (Fellow)
Languages
English (native); French (professional working proficiency); Japanese (elementary proficiency); Spanish (native or bilingual proficiency)
Research areas
AI in clinical trials; neurosymbolic / multi-agent AI architectures; digital health; real-world data activation; precision oncology systems
Clinical research experience
Phase I–III clinical trial leadership and portfolios across oncology networks
Leadership & recognition
- 40 under 40 in Cancer; Philadelphia Business Journal “40 Under 40”; Castle Connolly / Philadelphia Magazine Top Doctors (since 2018)
Publications & media
- 80+ peer-reviewed publications in NEJM AI, JCO, Lancet Oncology, ESMO and JAMA Oncology
- PubMed
Arturo Loaiza-Bonilla reviews Massive Bio content as part of our Medical Review Board, ensuring medical accuracy and clinical currency across our cancer resources.